Andreas G. Frank Sells 3,940 Shares of Hill-Rom Holdings, Inc. (HRC) Stock
Hill-Rom Holdings, Inc. (NYSE:HRC) SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of Hill-Rom Holdings, Inc. (HRC) traded down 1.81% during mid-day trading on Friday, hitting $75.60. 1,612,576 shares of the stock traded hands. The stock has a 50-day moving average of $75.42 and a 200-day moving average of $75.05. Hill-Rom Holdings, Inc. has a 52 week low of $50.50 and a 52 week high of $84.65. The company has a market cap of $4.98 billion, a price-to-earnings ratio of 44.06 and a beta of 1.21.
Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $689.10 million for the quarter, compared to the consensus estimate of $695.50 million. Hill-Rom Holdings had a net margin of 0.83% and a return on equity of 1.90%. Hill-Rom Holdings’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.81 EPS. Analysts anticipate that Hill-Rom Holdings, Inc. will post $3.82 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be issued a dividend of $0.18 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.95%. Hill-Rom Holdings’s dividend payout ratio is currently 41.62%.
WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/15/andreas-g-frank-sells-3940-shares-of-hill-rom-holdings-inc-hrc-stock.html.
HRC has been the subject of several analyst reports. Needham & Company LLC initiated coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “buy” rating and a $95.00 price target for the company. Zacks Investment Research upgraded Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $87.00 price target for the company in a report on Friday, June 2nd. Barclays PLC boosted their price target on Hill-Rom Holdings from $80.00 to $86.00 and gave the company an “overweight” rating in a report on Friday, June 9th. Stifel Nicolaus reiterated a “buy” rating and issued a $84.00 price target on shares of Hill-Rom Holdings in a report on Sunday, July 30th. Finally, ValuEngine upgraded Hill-Rom Holdings from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $88.17.
Institutional investors have recently added to or reduced their stakes in the company. Independent Portfolio Consultants Inc. raised its holdings in shares of Hill-Rom Holdings by 171.5% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after purchasing an additional 849 shares in the last quarter. Meadow Creek Investment Management LLC raised its holdings in shares of Hill-Rom Holdings by 3.9% during the 1st quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock valued at $120,000 after purchasing an additional 64 shares in the last quarter. Seven Eight Capital LP bought a new position in shares of Hill-Rom Holdings during the 2nd quarter valued at $127,000. Acrospire Investment Management LLC raised its holdings in shares of Hill-Rom Holdings by 43.4% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock valued at $158,000 after purchasing an additional 600 shares in the last quarter. Finally, Neuburgh Advisers LLC raised its holdings in shares of Hill-Rom Holdings by 3.9% during the 1st quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock valued at $165,000 after purchasing an additional 88 shares in the last quarter. Institutional investors and hedge funds own 82.31% of the company’s stock.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.